Merck

MRK Mega Cap

Healthcare · Drug Manufacturers - General

Updated: Apr 5, 2026, 00:03 UTC

$120.87

+0.02% today

52W: $73.31 – $125.14

52W Low: $73.31 Position: 91.8% 52W High: $125.14

🔗 Compare Brokers Best Broker for Beginners →

Key Metrics

P/E Ratio

16.6x

Price-to-Earnings

Forward P/E

12.41x

Forward Price/Earnings

P/S Ratio

4.6x

Price-to-Sales

EV/EBITDA

11.51x

Enterprise Value/EBITDA

Div. Yield

281%

Annual dividend yield

Market Cap

$298.8B

Market Capitalization

Revenue Growth

YoY Revenue Growth

Profit Margin

28.08%

Net profit margin

ROE

36.88%

Return on Equity

Beta

0.28

Market sensitivity

Short Interest

1.31%

% of float sold short

Avg. Volume

11,943,970

Average daily volume

Valuation Analysis

Signal

Undervalued

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

27 analysts

Avg. Price Target

$128.59

+6.39% upside

Target Range

$100.00 – $150.00

🚫 Not currently held by any of our 15 tracked Smart Money managers. View Smart Money Tracker →

About the Company

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Fl

Sector: Healthcare Industry: Drug Manufacturers - General Country: United States Employees: 73,000 Exchange: NYQ